Filing Flows › Glaukos (GKOS) › Q2 2025
Glaukos (GKOS) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 4, 2025
Glaukos (GKOS) reported revenue of $124M for the second quarter 2025 (Q2 2025), +30% from a year earlier and +16% from the quarter before. Operating margin was -18.3%, net loss $19.7M (15.8% of revenue).
Glaukos, Q2 2025: revenue $124M (+30% year over year), operating margin -18.3%, net loss $19.7M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $124M | +16% | +30% |
| Operating profit | −$22.7M | — | — |
| Net earnings | −$19.7M | — | — |
| Operating cash flow | $7.0M | — | — |
| Free cash flow | $5.8M | — | — |
What changed
Revenue was $124.1M in Q2 2025, up 30% year over year and up 16% from the previous quarter. Glaucoma was the largest line at 83% of revenue. Glaucoma added $27.7M year over year (up 36%), 97% of the total change.
Gross margin was 78.3%, up 1.9 points from a year earlier. Operating costs exceeded revenue by $22.7M, an operating margin of -18.3%. Operating expenses grew 16% against revenue growth of 30%. The fastest-growing cost line was SG&A (+26%). The quarter ended with a net loss of $19.7M, wider than the previous quarter's $18.1M loss.
Operating cash flow was $7.0M. Non-cash charges added back $8.6M of depreciation and amortization and $18.0M of share-based compensation. Capital expenditures of $1.2M left free cash flow of $5.8M.
Questions
What was Glaukos' revenue in the second quarter 2025?
Glaukos (GKOS) reported revenue of $124M for the second quarter 2025 (Q2 2025), +30% from a year earlier and +16% from the quarter before.
Was Glaukos profitable in the second quarter 2025?
Operating loss was $22.7M (-18.3% of revenue) and net loss $19.7M.
Source: Glaukos 10-Q on SEC EDGAR.